Voyager names Robin Swartz president; expected to succeed as CEO in Q1 2027

VYGR•2026-10-21

Voyager Therapeutics appointed Robin Swartz president and expects her to succeed CEO Dr. Sandrock in Q1 2027, after VY1706 safety data. Sandrock will remain CEO through Q1 2027 and continue as a board member.

1. CEO succession plan

Voyager Therapeutics appointed Robin Swartz president and expects her to succeed Dr. Sandrock as CEO in Q1 2027, after VY1706 safety data. Sandrock will remain CEO through Q1 2027 and continue as a board member.

Voyager names Robin Swartz president; expected to succeed as CEO in Q1 2027

1. CEO succession plan

Related News

Nomad Foods sets third-quarter results release

Parke Bancorp's Q3 net income rises, helped by loan growth

KKR private equity conglomerate's transactional net asset value per share ranges from $35.66 to $39.36

Five AI quirks and conundrums to watch this earnings season

Achieve Life Sciences reports 31.2% quit rate in 52-week cytisinicline trial